Cargando…

Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies

Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary hypertension. The patients most commonly encountered in clinical practice with group III PH include those with chronic obstructive lung disease (COPD), d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fein, Daniel G., Zaidi, Ali N., Sulica, Roxana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039478/
https://www.ncbi.nlm.nih.gov/pubmed/27571110
http://dx.doi.org/10.3390/jcm5090075
_version_ 1782456064228196352
author Fein, Daniel G.
Zaidi, Ali N.
Sulica, Roxana
author_facet Fein, Daniel G.
Zaidi, Ali N.
Sulica, Roxana
author_sort Fein, Daniel G.
collection PubMed
description Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary hypertension. The patients most commonly encountered in clinical practice with group III PH include those with chronic obstructive lung disease (COPD), diffuse parenchymal lung disease, and sleep-disordered breathing. The purpose of this review is to outline the variable clinical significance of pulmonary hypertension in the most common pulmonary disease states and how a clinician may approach the management of these patients.
format Online
Article
Text
id pubmed-5039478
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-50394782016-10-04 Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies Fein, Daniel G. Zaidi, Ali N. Sulica, Roxana J Clin Med Review Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary hypertension. The patients most commonly encountered in clinical practice with group III PH include those with chronic obstructive lung disease (COPD), diffuse parenchymal lung disease, and sleep-disordered breathing. The purpose of this review is to outline the variable clinical significance of pulmonary hypertension in the most common pulmonary disease states and how a clinician may approach the management of these patients. MDPI 2016-08-26 /pmc/articles/PMC5039478/ /pubmed/27571110 http://dx.doi.org/10.3390/jcm5090075 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fein, Daniel G.
Zaidi, Ali N.
Sulica, Roxana
Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
title Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
title_full Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
title_fullStr Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
title_full_unstemmed Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
title_short Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
title_sort pulmonary hypertension due to common respiratory conditions: classification, evaluation and management strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039478/
https://www.ncbi.nlm.nih.gov/pubmed/27571110
http://dx.doi.org/10.3390/jcm5090075
work_keys_str_mv AT feindanielg pulmonaryhypertensionduetocommonrespiratoryconditionsclassificationevaluationandmanagementstrategies
AT zaidialin pulmonaryhypertensionduetocommonrespiratoryconditionsclassificationevaluationandmanagementstrategies
AT sulicaroxana pulmonaryhypertensionduetocommonrespiratoryconditionsclassificationevaluationandmanagementstrategies